Wave Life Sciences (WVE) Total Non-Current Liabilities (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Total Non-Current Liabilities data on file, last reported at $54.0 million in Q2 2026.

• Quarterly Total Non-Current Liabilities rose 203.17% year-over-year to $54.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $54.0 million (up 203.17% YoY) and the FY2025 annual result came in at $17.2 million, down 27.92% from the prior year.
• Total Non-Current Liabilities improved to $54.0 million in Q2 2026, from $22.0 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $161.5 million in Q1 2023 to a low of $17.2 million in Q4 2025.
• A 5-year average of $66.2 million and a median of $39.6 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2024 — Total Non-Current Liabilities sank 77.63% — and 2026, when it surged 203.17%.
• Tracing WVE's Total Non-Current Liabilities over 5 years: stood at $112.1 million in 2022, then plunged by 63.42% to $41.0 million in 2023, then tumbled by 41.8% to $23.9 million in 2024, then dropped by 27.92% to $17.2 million in 2025, then jumped by 213.82% to $54.0 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $54.0 million (Q2 2026), $22.0 million (Q1 2026), and $17.2 million (Q4 2025), per Business Quant data.